- Home
- EVMN vs DGICB Comparison
EVMN vs DGICB Comparison
Compare EVMN & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | DGICB |
|---|---|---|
| Founded | 2020 | 1986 |
| Country | United States | United States |
| Employees | 48 | 851 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 869.1M | 889.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EVMN | DGICB |
|---|---|---|
| Price | $13.32 | $21.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $43.88 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 5.0K |
| Earning Date | 06-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.89 | $13.84 |
| 52 Week High | $33.20 | $24.00 |
Technical Indicators
Market Signals| Indicator | EVMN | DGICB |
|---|---|---|
| Relative Strength Index (RSI) | 29.23 | 59.57 |
| Support Level | N/A | $14.96 |
| Resistance Level | $20.37 | $23.69 |
| Average True Range (ATR) | 1.74 | 1.55 |
| MACD | -0.52 | 0.36 |
| Stochastic Oscillator | 0.59 | 93.58 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.